SGCM
ARRY

Sand Grove Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Sand Grove Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,369,707
Closed -$109M – 21
2019
Q2 		$109M Buy
+2,369,707
New +$66.5M 11.65% 3

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Sand Grove Capital Management's ARRY Position: Q3 2019 in Review

Sand Grove Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,369,707 shares — an estimated $109M sold.

Sand Grove Capital Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $109M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Sand Grove Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Sand Grove Capital Management sold 2,369,707 Array Biopharma Inc shares in Q3 2019, an estimated $109M.
  • Sand Grove Capital Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Sand Grove Capital Management's Array Biopharma Inc position peaked at $109M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Sand Grove Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.